UK markets closed

Blueprint Medicines Corporation (BPMC)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
86.85-2.05 (-2.31%)
At close: 04:00PM EDT
86.85 0.00 (0.00%)
After hours: 04:04PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
249,380
249,380
204,036
180,080
793,735
Cost of revenue
8,540
8,540
17,813
17,934
425
Gross profit
240,840
240,840
186,223
162,146
793,310
Operating expenses
Research development
427,720
427,720
477,419
601,033
326,860
Selling general and administrative
295,141
295,141
237,374
195,293
157,743
Total operating expenses
722,861
722,861
714,793
796,326
484,603
Operating income or loss
-482,021
-482,021
-528,570
-634,180
308,707
Total other income/expenses net
-5,202
-5,202
-6,944
-9,290
-366
Income before tax
-506,016
-506,016
-552,281
-641,084
314,940
Income tax expense
968
968
5,236
3,001
1,058
Income from continuing operations
-506,984
-506,984
-557,517
-644,085
313,882
Net income
-506,984
-506,984
-557,517
-644,085
313,882
Net income available to common shareholders
-506,984
-506,984
-557,517
-644,085
313,882
Basic EPS
-9.20
-8.37
-9.35
-11.01
5.76
Diluted EPS
-9.20
-8.37
-9.35
-11.01
5.59
Basic average shares
60,303
60,558
59,642
58,518
54,534
Diluted average shares
60,303
60,558
59,642
58,518
56,168